Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations Live Events 机制性 MIDD:凭借坚实的科学基础实现监管成功 2026 年 6 月 30 日 - 12:00 PM – 2:00 PMCertara2026 年 6 月 10 日
Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study Poster Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…Certara2026 年 6 月 9 日
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies Poster Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.Certara2026 年 6 月 9 日
Beyond Compliance: What ICH M15 Means for the Future of Drug Development Blog Beyond Compliance: What ICH M15 Means for the Future of Drug Development Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…Certara2026 年 6 月 9 日
Applying AI-Driven Biosimulation to Drug Discovery Video Applying AI-Driven Biosimulation to Drug Discovery Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…Certara2026 年 6 月 2 日
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators On-Demand Webinar The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…Certara2026 年 5 月 26 日
Certainty US 2026 recap: advancing model-informed drug development right from the start Blog Certainty US 2026 recap: advancing model-informed drug development right from the start This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…Certara2026 年 5 月 26 日
Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models Publication 尼拉帕利(Niraparib)群体药代动力学建模以评估不同吸收模型 This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…Certara2026 年 5 月 21 日
MIDD is Transforming Drug Development Video MIDD is Transforming Drug Development Recorded live at the US Certainty 2026 client conference in Boston, Certara clients who are…Certara2026 年 5 月 21 日
How to Leverage PBPK Modeling and Simulation in Drug Research and Development Guide 如何在药物研发中运用 PBPK 建模与模拟 Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…Certara2026 年 5 月 12 日